SOLID TUMOURS:@0.084848:0.038601:0.266058:0.038601:0.266058:0.019343:0.084848:0.019343:0.011712:0.020438:0.010866:0.005315:0.017498:0.006515:0.010019:0.015405:0.021613:0.020438:0.015405:0.014276:0.011712
64:@0.023705:0.038809:0.044778:0.038809:0.044778:0.019212:0.023705:0.019212:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.084848:0.970015:0.320957:0.970015:0.320957:0.956010:0.084848:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
n   :@0.084242:0.093046:0.107051:0.093046:0.107051:0.084606:0.084242:0.084606:0.009762:0.003566:0.005914:0.003566
Clinical progression: doubling of size :@0.103485:0.096166:0.443211:0.096166:0.443211:0.080410:0.103485:0.080410:0.015644:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.005330:0.013123:0.005727:0.012604:0.012950:0.005705:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.005330:0.005330:0.013181:0.012604:0.011699:0.013123:0.003848:0.003848:0.011738:0.012950:0.005330:0.012604:0.006042:0.005330:0.007466:0.003848:0.008178:0.012508:0.005330
is determined by TRUS or DRE, local :@0.103485:0.112557:0.433908:0.112557:0.433908:0.096801:0.103485:0.096801:0.003848:0.007466:0.005330:0.013181:0.012508:0.006523:0.012508:0.006323:0.018049:0.003848:0.011738:0.012508:0.013181:0.005330:0.013123:0.010314:0.005330:0.008197:0.011680:0.012604:0.009583:0.005330:0.012604:0.005792:0.005330:0.014316:0.011680:0.010314:0.005330:0.005330:0.003848:0.012604:0.012450:0.013143:0.003848:0.005330
progression or distant metastases:@0.103485:0.128947:0.410815:0.128947:0.410815:0.113192:0.103485:0.113192:0.013123:0.005715:0.012604:0.012950:0.005705:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.005330:0.012604:0.005792:0.005330:0.013181:0.003848:0.007466:0.006523:0.013143:0.011738:0.006523:0.005330:0.018049:0.012508:0.006523:0.013143:0.007466:0.006523:0.013143:0.007466:0.012508:0.007466
n   :@0.084242:0.142203:0.107051:0.142203:0.107051:0.133763:0.084242:0.133763:0.009762:0.003566:0.005914:0.003566
Gleason Score progression on repeat :@0.103485:0.145323:0.454645:0.145323:0.454645:0.129567:0.103485:0.129567:0.016779:0.003848:0.012508:0.013143:0.007466:0.012604:0.011738:0.005330:0.009583:0.012450:0.012604:0.005707:0.012508:0.005330:0.013123:0.005711:0.012604:0.012950:0.005705:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.005330:0.012604:0.011738:0.005330:0.005703:0.012508:0.013123:0.012508:0.013143:0.006523:0.005330
biopsies.:@0.103485:0.161713:0.182802:0.161713:0.182802:0.145958:0.103485:0.145958:0.013123:0.003848:0.012604:0.013123:0.007466:0.003848:0.012508:0.007466:0.005330
RADICAL PROSTATECTOMY (PLUS  :@0.084242:0.194803:0.427997:0.194803:0.427997:0.176988:0.084242:0.176988:0.012401:0.015822:0.014966:0.005987:0.016677:0.015822:0.009407:0.005987:0.011973:0.012401:0.017960:0.011118:0.008980:0.015822:0.008980:0.011118:0.016677:0.008980:0.017960:0.019242:0.013256:0.005987:0.008125:0.011973:0.009407:0.013683:0.011118:0.005944:0.005987
OR MINUS LYMPH-NODE DISSECTION):@0.084242:0.212662:0.463532:0.212662:0.463532:0.194847:0.084242:0.194847:0.017960:0.012401:0.005987:0.019242:0.005987:0.015822:0.013683:0.011118:0.005987:0.009407:0.013256:0.019242:0.011973:0.014539:0.008980:0.015822:0.017960:0.014966:0.011118:0.005987:0.014966:0.005987:0.011118:0.011118:0.011118:0.016677:0.008980:0.005987:0.017960:0.015822:0.008125
Eligible patients include all risk groups if :@0.084242:0.230191:0.480476:0.230191:0.480476:0.214435:0.084242:0.214435:0.010314:0.003848:0.003848:0.012950:0.003848:0.013123:0.003848:0.012508:0.010237:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.010237:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.010237:0.013143:0.003848:0.003848:0.010237:0.005792:0.003848:0.007466:0.009660:0.010237:0.012950:0.005709:0.012604:0.011699:0.013123:0.007466:0.010237:0.003848:0.006042:0.005330
general  medical condition,  life expec-:@0.084242:0.246582:0.475156:0.246582:0.475156:0.230826:0.084242:0.230826:0.012950:0.012508:0.011738:0.012508:0.005792:0.013143:0.003848:0.005330:0.008432:0.018049:0.012508:0.013181:0.003848:0.012450:0.013143:0.003848:0.013778:0.012450:0.012604:0.011738:0.013181:0.003848:0.006523:0.003848:0.012604:0.011738:0.005330:0.005330:0.008428:0.003848:0.003848:0.006042:0.012508:0.013778:0.012508:0.009236:0.013123:0.012508:0.012450:0.006388
tancy  and possible complications are :@0.084242:0.262973:0.480492:0.262973:0.480492:0.247217:0.084242:0.247217:0.006523:0.013143:0.011738:0.012450:0.010314:0.005330:0.010073:0.013143:0.011738:0.013181:0.015413:0.013123:0.012604:0.007466:0.007466:0.003848:0.013123:0.003848:0.012508:0.015413:0.012450:0.012604:0.018049:0.013123:0.003848:0.003848:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.015413:0.013143:0.005715:0.012508:0.005330
justified. (Prostatectomy in metastatic dis-:@0.084242:0.279364:0.475146:0.279364:0.475146:0.263608:0.084242:0.263608:0.003906:0.011699:0.007466:0.006523:0.003848:0.004686:0.004686:0.012508:0.013181:0.005330:0.006879:0.007100:0.011392:0.005711:0.012604:0.007466:0.006523:0.013143:0.006523:0.012508:0.012450:0.006523:0.012604:0.018049:0.010314:0.006871:0.003848:0.011738:0.006881:0.018049:0.012508:0.006523:0.013143:0.007466:0.006523:0.013143:0.006523:0.003848:0.012450:0.006883:0.013181:0.003848:0.007466:0.006388
ease is still regarded as experimental and :@0.084242:0.295754:0.480495:0.295754:0.480495:0.279999:0.084242:0.279999:0.012508:0.013143:0.007466:0.012508:0.006350:0.003848:0.007466:0.006350:0.007466:0.006523:0.003848:0.003848:0.003848:0.006350:0.005711:0.012508:0.012950:0.013143:0.005675:0.013181:0.012508:0.013181:0.006350:0.013143:0.007466:0.006350:0.012508:0.009236:0.013123:0.012508:0.005792:0.003848:0.018049:0.012508:0.011738:0.006523:0.013143:0.003848:0.006350:0.013143:0.011738:0.013181:0.005330
should be done in a clinical trial situation.):@0.084242:0.312145:0.474632:0.312145:0.474632:0.296389:0.084242:0.296389:0.007466:0.011738:0.012604:0.011699:0.003848:0.013181:0.005330:0.013123:0.012508:0.005330:0.013181:0.012604:0.011738:0.012508:0.005330:0.003848:0.011738:0.005330:0.013143:0.005330:0.012450:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.005330:0.006523:0.005792:0.003848:0.013143:0.003848:0.005330:0.007466:0.003848:0.006523:0.011699:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.007100
The  advantage of  radical prostatecto-:@0.102426:0.328536:0.475152:0.328536:0.475152:0.312780:0.102426:0.312780:0.008197:0.011738:0.012508:0.005330:0.003085:0.013143:0.013181:0.010660:0.013143:0.011738:0.006523:0.013143:0.012950:0.012508:0.008428:0.012604:0.006042:0.005330:0.003088:0.005792:0.013143:0.013181:0.003848:0.012450:0.013143:0.003848:0.008428:0.013123:0.005715:0.012604:0.007466:0.006523:0.013143:0.006523:0.012508:0.012450:0.006523:0.012588:0.006388
my, plus or minus lymph-node dissection, :@0.084242:0.344927:0.480490:0.344927:0.480490:0.329171:0.084242:0.329171:0.018049:0.010314:0.005330:0.007889:0.013123:0.003848:0.011699:0.007466:0.007889:0.012604:0.005792:0.007878:0.018049:0.003848:0.011738:0.011699:0.007466:0.007889:0.003848:0.010314:0.018049:0.013123:0.011738:0.006388:0.011738:0.012604:0.013181:0.012508:0.007889:0.013181:0.003848:0.007466:0.007466:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738:0.005330:0.005330
is the potential of complete cure and/or :@0.084242:0.361318:0.480507:0.361318:0.480507:0.345562:0.084242:0.345562:0.003848:0.007466:0.007928:0.006523:0.011738:0.012508:0.007909:0.013123:0.012604:0.006523:0.012508:0.011738:0.006523:0.003848:0.013143:0.003848:0.007928:0.012604:0.006042:0.007911:0.012450:0.012604:0.018049:0.013123:0.003848:0.012508:0.006523:0.012508:0.007911:0.012450:0.011699:0.005711:0.012508:0.007914:0.013143:0.011738:0.013181:0.008409:0.012604:0.005792:0.005330
effective long-term control.:@0.084242:0.377709:0.339762:0.377709:0.339762:0.361953:0.084242:0.361953:0.012508:0.006096:0.006042:0.012508:0.012450:0.006523:0.003848:0.010660:0.012508:0.005330:0.003848:0.012604:0.011738:0.012950:0.006388:0.006523:0.012508:0.006312:0.018049:0.005330:0.012450:0.012604:0.011738:0.006523:0.005700:0.012604:0.003848:0.005330
Full pathological staging is possible and :@0.102426:0.394100:0.480497:0.394100:0.480497:0.378344:0.102426:0.378344:0.009333:0.011699:0.003848:0.003848:0.006437:0.013123:0.013143:0.006523:0.011738:0.012604:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.006446:0.007466:0.006523:0.013143:0.012950:0.003848:0.011738:0.012950:0.006433:0.003848:0.007466:0.006446:0.013123:0.012604:0.007466:0.007466:0.003848:0.013123:0.003848:0.012508:0.006446:0.013143:0.011738:0.013181:0.005330
gives detail on the  spread and charac-:@0.084242:0.410491:0.475163:0.410491:0.475163:0.394735:0.084242:0.394735:0.012950:0.003848:0.010660:0.012508:0.007466:0.009506:0.013181:0.012508:0.006523:0.013143:0.003848:0.003848:0.009506:0.012604:0.011738:0.009506:0.006523:0.011738:0.012508:0.005330:0.004164:0.007466:0.013123:0.005719:0.012508:0.013143:0.013181:0.009506:0.013143:0.011738:0.013181:0.009506:0.012450:0.011738:0.013143:0.005792:0.013143:0.012450:0.006388
ter of the tumour. The disadvantages are :@0.084242:0.426882:0.480497:0.426882:0.480497:0.411126:0.084242:0.411126:0.006523:0.012508:0.005792:0.007274:0.012604:0.006042:0.007274:0.006523:0.011738:0.012508:0.007274:0.006523:0.011699:0.018049:0.012594:0.011699:0.004378:0.005330:0.007274:0.008197:0.011738:0.012508:0.007274:0.013181:0.003848:0.007466:0.013143:0.013181:0.010676:0.013143:0.011738:0.006523:0.013143:0.012950:0.012508:0.007466:0.007274:0.013143:0.005715:0.012508:0.005330
anaesthetic and other possible complica-:@0.084242:0.443273:0.475144:0.443273:0.475144:0.427517:0.084242:0.427517:0.013143:0.011738:0.013143:0.012508:0.007466:0.006523:0.011738:0.012508:0.006523:0.003848:0.012450:0.005548:0.013143:0.011738:0.013181:0.005551:0.012604:0.006523:0.011738:0.012508:0.005792:0.005534:0.013123:0.012604:0.007466:0.007466:0.003848:0.013123:0.003864:0.012508:0.005550:0.012450:0.012604:0.018049:0.013123:0.003848:0.003848:0.012450:0.013143:0.006388
tions during surgery, which include bleed-:@0.084242:0.459664:0.475160:0.459664:0.475160:0.443908:0.084242:0.443908:0.006523:0.003848:0.012604:0.011738:0.007466:0.006215:0.013181:0.011699:0.005792:0.003848:0.011738:0.012950:0.006215:0.007466:0.011699:0.005809:0.012950:0.012508:0.005792:0.010314:0.005330:0.006206:0.015990:0.011738:0.003848:0.012450:0.011738:0.006215:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.006215:0.013123:0.003848:0.012508:0.012508:0.013181:0.006388
ing, embolism, mortality risks, incontinence :@0.084242:0.476055:0.480482:0.476055:0.480482:0.460299:0.084242:0.460299:0.003848:0.011738:0.012950:0.005330:0.004580:0.012508:0.018049:0.013123:0.012604:0.003848:0.003848:0.007466:0.018049:0.005330:0.004580:0.018049:0.012604:0.005792:0.006523:0.013143:0.003848:0.003848:0.006523:0.010314:0.004580:0.005792:0.003848:0.007466:0.009660:0.007466:0.005330:0.004580:0.003848:0.011738:0.012450:0.012604:0.011738:0.006523:0.003848:0.011738:0.012508:0.011738:0.012450:0.012508:0.005330
post-surgery,  and impaired erectile func-:@0.084242:0.492446:0.475165:0.492446:0.475165:0.476690:0.084242:0.476690:0.013123:0.012604:0.007466:0.006523:0.006388:0.007466:0.011699:0.005807:0.012950:0.012508:0.005792:0.010314:0.005330:0.005330:0.002973:0.013143:0.011738:0.013181:0.008313:0.003848:0.018049:0.013123:0.013143:0.003848:0.005725:0.012508:0.013181:0.008313:0.012508:0.005713:0.012508:0.012450:0.006523:0.003848:0.003848:0.012508:0.008313:0.006042:0.011699:0.011738:0.012450:0.006388
tion. The patient should discuss various :@0.084242:0.508837:0.480463:0.508837:0.480463:0.493081:0.084242:0.493081:0.006523:0.003848:0.012604:0.011738:0.005330:0.012334:0.008197:0.011738:0.012508:0.012334:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.012334:0.007466:0.011738:0.012604:0.011699:0.003848:0.013181:0.012334:0.013181:0.003848:0.007466:0.012450:0.011699:0.007466:0.007466:0.012334:0.010660:0.013143:0.005792:0.003848:0.012604:0.011699:0.007466:0.005330
procedures, i.e., open (retro-pubic or per-:@0.084242:0.525228:0.475160:0.525228:0.475160:0.509472:0.084242:0.509472:0.013123:0.005715:0.012604:0.012450:0.012508:0.013181:0.011699:0.005705:0.012508:0.007466:0.005330:0.005869:0.003848:0.005330:0.012508:0.005330:0.005330:0.005859:0.012604:0.013123:0.012508:0.011738:0.005859:0.007100:0.005715:0.012508:0.006523:0.005707:0.012604:0.006388:0.013123:0.011699:0.013123:0.003848:0.012450:0.005869:0.012604:0.005792:0.005855:0.013123:0.012508:0.005792:0.006388
ineal) or robotic-assisted, with his urologist.:@0.084242:0.541619:0.475173:0.541619:0.475173:0.525863:0.084242:0.525863:0.003848:0.011738:0.012508:0.013143:0.003848:0.007100:0.005292:0.012604:0.005792:0.005272:0.005713:0.012604:0.013123:0.012604:0.006523:0.003848:0.012450:0.006388:0.013143:0.007466:0.007466:0.003848:0.007466:0.006523:0.012508:0.013181:0.005330:0.005292:0.015990:0.003848:0.006523:0.011738:0.005280:0.011738:0.003848:0.007466:0.005292:0.011699:0.005711:0.012604:0.003848:0.012604:0.012950:0.003848:0.007466:0.006523:0.005330
EXTERNAL BEAM RADIOTHERAPY:@0.084242:0.574613:0.409225:0.574613:0.409225:0.556798:0.084242:0.556798:0.011118:0.014539:0.008980:0.011118:0.012401:0.015822:0.015822:0.009407:0.005987:0.012401:0.011118:0.015822:0.019242:0.005987:0.012401:0.015822:0.014966:0.005987:0.017960:0.008980:0.014539:0.011118:0.012401:0.015822:0.011973:0.013256
Eligible patients are from all risk groups, but :@0.084242:0.592145:0.480488:0.592145:0.480488:0.576389:0.084242:0.576389:0.010314:0.003848:0.003848:0.012950:0.003848:0.013123:0.003848:0.012508:0.004310:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.004310:0.013143:0.005713:0.012508:0.004310:0.006042:0.005711:0.012604:0.018049:0.004299:0.013143:0.003848:0.003848:0.004310:0.005792:0.003848:0.007466:0.009660:0.004310:0.012950:0.005709:0.012604:0.011699:0.013123:0.007466:0.005330:0.004301:0.013123:0.011699:0.006523:0.005330
it is ideal for intermediate-risk groups as all :@0.084242:0.608536:0.480470:0.608536:0.480470:0.592780:0.084242:0.592780:0.003848:0.006523:0.005626:0.003848:0.007466:0.005628:0.003848:0.013181:0.012508:0.013143:0.003848:0.005628:0.006042:0.012604:0.005792:0.005617:0.003848:0.011738:0.006523:0.012508:0.006321:0.018049:0.012508:0.013181:0.003848:0.013143:0.006523:0.012508:0.006388:0.005792:0.003848:0.007466:0.009660:0.005628:0.012950:0.005711:0.012604:0.011699:0.013123:0.007466:0.005625:0.013143:0.007466:0.005638:0.013143:0.003848:0.003848:0.005330
lymph-node groups can be covered in :@0.084242:0.624927:0.480490:0.624927:0.480490:0.609171:0.084242:0.609171:0.003848:0.010314:0.018049:0.013123:0.011738:0.006388:0.011738:0.012604:0.013181:0.012508:0.011141:0.012950:0.005709:0.012604:0.011699:0.013123:0.007466:0.011141:0.012450:0.013143:0.011738:0.011141:0.013123:0.012508:0.011141:0.012450:0.012604:0.010660:0.012508:0.005709:0.012508:0.013181:0.011141:0.003848:0.011738:0.005330
the treatment fields.:@0.084242:0.641318:0.270590:0.641318:0.270590:0.625562:0.084242:0.625562:0.006523:0.011738:0.012508:0.005330:0.006523:0.005700:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.004686:0.004686:0.012508:0.003848:0.013181:0.007466:0.005330
The  minimal radiotherapy  for  radical :@0.102426:0.657709:0.480482:0.657709:0.480482:0.641953:0.102426:0.641953:0.008197:0.011738:0.012508:0.005330:0.008715:0.018049:0.003848:0.011738:0.003848:0.018049:0.013143:0.003848:0.014066:0.005792:0.013143:0.013181:0.003848:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.008721:0.006042:0.012604:0.005792:0.005330:0.008715:0.005792:0.013143:0.013181:0.003848:0.012450:0.013143:0.003848:0.005330
treatment should be conformal radiother-:@0.084242:0.674100:0.475152:0.674100:0.475152:0.658344:0.084242:0.658344:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005798:0.007466:0.011738:0.012604:0.011699:0.003848:0.013181:0.005811:0.013123:0.012508:0.005811:0.012450:0.012604:0.011738:0.006042:0.012604:0.006312:0.018049:0.013143:0.003848:0.005811:0.005792:0.013143:0.013181:0.003848:0.012604:0.006523:0.011738:0.012508:0.005773:0.006388
apy (CRT). Intensity-modulated radiother-:@0.084242:0.690491:0.475152:0.690491:0.475152:0.674735:0.084242:0.674735:0.013143:0.013123:0.010314:0.007177:0.007100:0.015644:0.011794:0.008197:0.007100:0.005330:0.007177:0.004349:0.011738:0.006523:0.012508:0.011738:0.007466:0.003848:0.006523:0.010314:0.006388:0.018049:0.012604:0.013181:0.011699:0.003848:0.013143:0.006523:0.012508:0.013181:0.007177:0.005792:0.013143:0.013181:0.003848:0.012604:0.006523:0.011738:0.012508:0.005775:0.006388
apy (IMRT) allows for the sparing of other :@0.084242:0.706882:0.480490:0.706882:0.480490:0.691126:0.084242:0.691126:0.013143:0.013123:0.010314:0.007170:0.007100:0.004349:0.017684:0.011796:0.008197:0.007100:0.007158:0.013143:0.003848:0.003848:0.012604:0.015990:0.007466:0.007174:0.006042:0.012604:0.005792:0.007158:0.006523:0.011738:0.012508:0.007158:0.007466:0.013123:0.013143:0.005792:0.003848:0.011738:0.012950:0.007158:0.012604:0.006042:0.007158:0.012604:0.006523:0.011738:0.012508:0.005792:0.005330
pelvic organs – e.g., bladder and rectum, :@0.084242:0.723272:0.480515:0.723272:0.480515:0.707517:0.084242:0.707517:0.013123:0.012508:0.003848:0.010660:0.003848:0.012450:0.005773:0.012604:0.005807:0.012950:0.013143:0.011738:0.007466:0.005773:0.009621:0.005773:0.012508:0.005330:0.012950:0.005330:0.005330:0.005753:0.013123:0.003848:0.013143:0.013181:0.013181:0.012508:0.005792:0.005773:0.013143:0.011738:0.013181:0.005773:0.005713:0.012508:0.012450:0.006523:0.011699:0.018049:0.005330:0.005330
reducing possible side effects consider-:@0.084242:0.739663:0.475146:0.739663:0.475146:0.723907:0.084242:0.723907:0.005713:0.012508:0.013181:0.011699:0.012450:0.003848:0.011738:0.012950:0.011565:0.013123:0.012604:0.007466:0.007466:0.003848:0.013123:0.003848:0.012508:0.011565:0.007466:0.003848:0.013181:0.012508:0.011565:0.012508:0.006096:0.006042:0.012508:0.012450:0.006523:0.007466:0.011565:0.012450:0.012604:0.011738:0.007466:0.003848:0.013181:0.012508:0.005792:0.006388
ably. Image-guided radiotherapy tech-:@0.084242:0.756054:0.475152:0.756054:0.475152:0.740298:0.084242:0.740298:0.013143:0.013123:0.003848:0.010314:0.005330:0.013027:0.004349:0.018049:0.013143:0.012950:0.012508:0.006388:0.012950:0.011699:0.003848:0.013181:0.012508:0.013181:0.013027:0.005792:0.013143:0.013181:0.003848:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.013027:0.006523:0.012508:0.012450:0.011738:0.006388
niques take organ movement into consid-:@0.084242:0.772445:0.475135:0.772445:0.475135:0.756689:0.084242:0.756689:0.011738:0.003848:0.013123:0.011699:0.012508:0.007466:0.005484:0.006523:0.013143:0.009660:0.012508:0.005484:0.012604:0.005804:0.012950:0.013143:0.011738:0.005484:0.018049:0.012604:0.010660:0.012508:0.018049:0.012508:0.011738:0.006514:0.005484:0.003848:0.011738:0.006523:0.012604:0.005484:0.012450:0.012604:0.011738:0.007466:0.003848:0.013181:0.006388
eration.:@0.084242:0.788836:0.155728:0.788836:0.155728:0.773080:0.084242:0.773080:0.012508:0.005792:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330
The  advantages are long-term cancer :@0.102426:0.805227:0.480494:0.805227:0.480494:0.789471:0.102426:0.789471:0.008197:0.011738:0.012508:0.005330:0.003531:0.013143:0.013181:0.010660:0.013143:0.011738:0.006523:0.013143:0.012950:0.012508:0.007466:0.008871:0.013143:0.005715:0.012508:0.008871:0.003848:0.012604:0.011738:0.012950:0.006388:0.006523:0.012508:0.006313:0.018049:0.008871:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330
control; in fact the procedure can be cu-:@0.084242:0.821618:0.475156:0.821618:0.475156:0.805862:0.084242:0.805862:0.012450:0.012604:0.011738:0.006523:0.005703:0.012604:0.003848:0.005330:0.006084:0.003848:0.011738:0.006090:0.006042:0.013143:0.012450:0.006523:0.006086:0.006523:0.011738:0.012508:0.006083:0.013123:0.005715:0.012604:0.012450:0.012508:0.013181:0.011699:0.005705:0.012508:0.006088:0.012450:0.013143:0.011738:0.006086:0.013123:0.012508:0.006090:0.012450:0.011699:0.006388
rative. These are non-invasive treatments :@0.084242:0.838009:0.480495:0.838009:0.480495:0.822253:0.084242:0.822253:0.005792:0.013143:0.006523:0.003848:0.010660:0.012508:0.005330:0.008082:0.008197:0.011738:0.012508:0.007466:0.012508:0.008072:0.013143:0.005713:0.012508:0.008072:0.011738:0.012604:0.011738:0.006388:0.003848:0.011738:0.010660:0.013143:0.007466:0.003848:0.010660:0.012508:0.008082:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.007466:0.005330
reducing the risk of urinary incontinence. :@0.084242:0.854400:0.480507:0.854400:0.480507:0.838644:0.084242:0.838644:0.005713:0.012508:0.013181:0.011699:0.012450:0.003848:0.011738:0.012950:0.007861:0.006523:0.011738:0.012508:0.007859:0.005792:0.003848:0.007466:0.009660:0.007870:0.012604:0.006042:0.007870:0.011699:0.005792:0.003848:0.011738:0.013143:0.005792:0.010314:0.007861:0.003848:0.011738:0.012450:0.012604:0.011738:0.006523:0.003848:0.011738:0.012508:0.011738:0.012450:0.012508:0.005330:0.005330
Erectile  function  is often  preserved.  Pa-:@0.084242:0.870791:0.475167:0.870791:0.475167:0.855035:0.084242:0.855035:0.010314:0.005715:0.012508:0.012450:0.006523:0.003848:0.003848:0.012508:0.005330:0.005896:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738:0.005330:0.005894:0.003848:0.007466:0.011238:0.012604:0.006042:0.006523:0.012508:0.011738:0.005330:0.005884:0.013123:0.005715:0.012508:0.007466:0.012508:0.005792:0.010660:0.012508:0.013181:0.005330:0.005330:0.005894:0.011392:0.013143:0.006388
tients can remain productive at work and :@0.084242:0.887182:0.480490:0.887182:0.480490:0.871426:0.084242:0.871426:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005984:0.012450:0.013143:0.011738:0.005984:0.005713:0.012508:0.018049:0.013143:0.003848:0.011738:0.005984:0.013123:0.005715:0.012604:0.013181:0.011699:0.012450:0.006523:0.003848:0.010660:0.012508:0.005984:0.013143:0.006523:0.005984:0.015990:0.012604:0.005792:0.009660:0.005975:0.013143:0.011738:0.013181:0.005330
attend radiation before or after work.:@0.084242:0.903573:0.432588:0.903573:0.432588:0.887817:0.084242:0.887817:0.013143:0.006523:0.006523:0.012508:0.011738:0.013181:0.005330:0.005792:0.013143:0.013181:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.013123:0.012508:0.006042:0.012604:0.005696:0.012508:0.005330:0.012604:0.005792:0.005330:0.013143:0.006042:0.006523:0.012508:0.005792:0.005330:0.015990:0.012604:0.005792:0.009660:0.005330
The disadvantages of these treatments :@0.102426:0.919964:0.480484:0.919964:0.480484:0.904208:0.102426:0.904208:0.008005:0.011545:0.012315:0.009352:0.012989:0.003656:0.007274:0.012950:0.012989:0.010468:0.012950:0.011545:0.006331:0.012950:0.012758:0.012315:0.007274:0.009352:0.012411:0.005850:0.009352:0.006331:0.011545:0.012315:0.007274:0.012315:0.009352:0.006331:0.005521:0.012315:0.012950:0.006331:0.017857:0.012315:0.011545:0.006331:0.007470:0.005330
are that they are delivered over a period of :@0.084242:0.936355:0.480494:0.936355:0.480494:0.920599:0.084242:0.920599:0.012950:0.005521:0.012315:0.004195:0.006331:0.011545:0.012950:0.006331:0.004195:0.006331:0.011545:0.012315:0.010122:0.004195:0.012950:0.005521:0.012315:0.004195:0.012989:0.012315:0.003656:0.003656:0.010468:0.012315:0.005519:0.012315:0.012989:0.004195:0.012411:0.010468:0.012315:0.005600:0.004195:0.012950:0.004195:0.012931:0.012315:0.005600:0.003656:0.012411:0.012989:0.004195:0.012411:0.006042:0.005330
six weeks of daily treatment. Acute symp-:@0.523643:0.096276:0.914529:0.096276:0.914529:0.080520:0.523643:0.080520:0.007274:0.003656:0.009044:0.007408:0.015798:0.012315:0.012315:0.009467:0.007274:0.007408:0.012411:0.005850:0.007408:0.012989:0.012950:0.003656:0.003656:0.010122:0.007408:0.006331:0.005519:0.012315:0.012950:0.006331:0.017857:0.012315:0.011545:0.006331:0.005138:0.007408:0.014047:0.012257:0.011507:0.006331:0.012315:0.007408:0.007274:0.010122:0.017857:0.012931:0.006388
toms appear typically during the third :@0.523643:0.112694:0.919861:0.112694:0.919861:0.096938:0.523643:0.096938:0.006331:0.012411:0.017857:0.007274:0.014643:0.012950:0.012931:0.012931:0.012315:0.012950:0.005600:0.014643:0.006331:0.010122:0.012931:0.003656:0.012257:0.012950:0.003656:0.003656:0.010122:0.014643:0.012989:0.011507:0.005600:0.003656:0.011545:0.012758:0.014643:0.006331:0.011545:0.012315:0.014643:0.006331:0.011545:0.003656:0.005482:0.013181:0.005330
week of radiation and resolve within days :@0.523643:0.129111:0.919902:0.129111:0.919902:0.113355:0.523643:0.113355:0.015798:0.012315:0.012315:0.009467:0.007197:0.012411:0.005850:0.007197:0.005600:0.012950:0.012989:0.003656:0.012950:0.006331:0.003656:0.012411:0.011545:0.007197:0.012950:0.011545:0.012989:0.007197:0.005519:0.012315:0.007274:0.012411:0.003656:0.010468:0.012315:0.007197:0.015798:0.003656:0.006331:0.011545:0.003656:0.011545:0.007197:0.012989:0.012950:0.010122:0.007470:0.005330
or weeks after completion of radiotherapy.:@0.523643:0.145528:0.914571:0.145528:0.914571:0.129772:0.523643:0.129772:0.012411:0.005600:0.004868:0.015798:0.012315:0.012315:0.009467:0.007274:0.004868:0.012950:0.005850:0.006331:0.012315:0.005600:0.004868:0.012257:0.012411:0.017857:0.012931:0.003656:0.012315:0.006331:0.003656:0.012411:0.011545:0.004868:0.012411:0.005850:0.004868:0.005600:0.012950:0.012989:0.003656:0.012411:0.006331:0.011545:0.012315:0.005600:0.012950:0.012931:0.010122:0.005330
Late toxicities include chronic urethritis in :@0.541827:0.161946:0.919886:0.161946:0.919886:0.146190:0.541827:0.146190:0.008890:0.013143:0.006523:0.012508:0.004349:0.006523:0.012604:0.009236:0.003848:0.012450:0.003848:0.006523:0.003848:0.012508:0.007466:0.004362:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.004349:0.012450:0.011738:0.005709:0.012604:0.011738:0.003848:0.012450:0.004349:0.011699:0.005711:0.012508:0.006523:0.011738:0.005792:0.003848:0.006523:0.003848:0.007466:0.004349:0.003848:0.011738:0.005330
10% of patients with strictures in 2% of pa-:@0.523643:0.178363:0.914564:0.178363:0.914564:0.162607:0.523643:0.162607:0.010660:0.010660:0.014913:0.006331:0.012604:0.006042:0.006321:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.006331:0.015990:0.003848:0.006523:0.011738:0.006331:0.007466:0.006523:0.005792:0.003848:0.012450:0.006523:0.011699:0.005707:0.012508:0.007466:0.006331:0.003848:0.011738:0.006331:0.010660:0.014913:0.006331:0.012604:0.006042:0.006321:0.013123:0.013143:0.006388
tients. Haemorrhagic cystitis has become :@0.523643:0.194781:0.919886:0.194781:0.919886:0.179025:0.523643:0.179025:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.007312:0.013143:0.013143:0.012508:0.018049:0.012604:0.005792:0.006335:0.011738:0.013143:0.012950:0.003848:0.012450:0.007312:0.012450:0.010314:0.007466:0.006523:0.003848:0.006523:0.003848:0.007466:0.007312:0.011738:0.013143:0.007466:0.007312:0.013123:0.012508:0.012450:0.012604:0.018049:0.012508:0.005330
uncommon with CRT.:@0.523643:0.211198:0.720908:0.211198:0.720908:0.195442:0.523643:0.195442:0.011699:0.011738:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.005330:0.015990:0.003848:0.006523:0.011738:0.005330:0.015644:0.011769:0.006831:0.005330
Grade 2 or 3 rectal toxicities at 10 years :@0.541827:0.227615:0.919861:0.227615:0.919861:0.211859:0.541827:0.211859:0.016779:0.005792:0.013143:0.013181:0.012508:0.006042:0.010660:0.006042:0.012604:0.005792:0.006042:0.010660:0.006042:0.005713:0.012508:0.012450:0.006523:0.013143:0.003848:0.006042:0.006523:0.012604:0.009236:0.003848:0.012450:0.003848:0.006523:0.003848:0.012508:0.007466:0.006042:0.013143:0.006523:0.006042:0.010660:0.010660:0.006042:0.010314:0.012508:0.013143:0.005792:0.007466:0.005330
are 8% for CRT and 1% for IMRT. Impotency :@0.523643:0.244033:0.919875:0.244033:0.919875:0.228277:0.523643:0.228277:0.013143:0.005715:0.012508:0.004772:0.010660:0.014913:0.004772:0.006042:0.012604:0.005792:0.004772:0.015644:0.011792:0.008197:0.004772:0.013143:0.011738:0.013181:0.004772:0.010660:0.014913:0.004772:0.006042:0.012604:0.005792:0.004772:0.004349:0.017684:0.011792:0.006831:0.005330:0.004772:0.004349:0.018049:0.013123:0.012604:0.006523:0.012508:0.011738:0.012450:0.010314:0.005330
rates after EBRT vary in reports between :@0.523643:0.260450:0.919880:0.260450:0.919880:0.244694:0.523643:0.244694:0.005792:0.013143:0.006523:0.012508:0.007466:0.009333:0.013143:0.006042:0.006523:0.012508:0.005792:0.009333:0.010314:0.011045:0.011798:0.008197:0.009333:0.010660:0.013143:0.005792:0.010314:0.009333:0.003848:0.011738:0.009333:0.005711:0.012508:0.013123:0.012604:0.005792:0.006523:0.007466:0.009333:0.013123:0.012508:0.006523:0.015990:0.012508:0.012508:0.011738:0.005330
36% and 68% three years after treatment. :@0.523643:0.276867:0.919871:0.276867:0.919871:0.261112:0.523643:0.261112:0.010660:0.010660:0.014913:0.006600:0.013143:0.011738:0.013181:0.006600:0.010660:0.010660:0.014913:0.006600:0.006523:0.011738:0.005709:0.012508:0.012508:0.006600:0.010314:0.012508:0.013143:0.005792:0.007466:0.006600:0.013143:0.006042:0.006523:0.012508:0.005792:0.006600:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.005330
The heterogeneity in the population treat-:@0.523643:0.293285:0.914566:0.293285:0.914566:0.277529:0.523643:0.277529:0.008197:0.011738:0.012508:0.005415:0.011738:0.012508:0.006523:0.012508:0.005711:0.012604:0.012950:0.012508:0.011738:0.012494:0.003848:0.006523:0.010314:0.005426:0.003848:0.011738:0.005426:0.006523:0.011738:0.012508:0.005417:0.013123:0.012604:0.013123:0.011699:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005426:0.006523:0.005709:0.012508:0.013143:0.006523:0.006388
ed  with  EBRT  probably explains the  vari-:@0.523643:0.309702:0.914541:0.309702:0.914541:0.293946:0.523643:0.293946:0.012508:0.013181:0.005330:0.003877:0.015990:0.003848:0.006523:0.011738:0.005330:0.003877:0.010314:0.011045:0.011798:0.008197:0.005330:0.003873:0.013123:0.005711:0.012604:0.013123:0.013143:0.013123:0.003848:0.010314:0.009217:0.012508:0.009236:0.013123:0.003848:0.013143:0.003848:0.011738:0.007466:0.009217:0.006523:0.011738:0.012508:0.005330:0.003872:0.010660:0.013143:0.005792:0.003848:0.006388
ability of erectile dysfunction.:@0.523643:0.326120:0.795771:0.326120:0.795771:0.310364:0.523643:0.310364:0.013143:0.013123:0.003848:0.003848:0.003848:0.006523:0.010314:0.005330:0.012604:0.006042:0.005330:0.012508:0.005717:0.012508:0.012450:0.006523:0.003848:0.003848:0.012508:0.005330:0.013181:0.010314:0.007466:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738:0.005330
Newer radiotherapy systems use Rapid- :@0.541827:0.342537:0.919886:0.342537:0.919886:0.326781:0.541827:0.326781:0.014239:0.012508:0.015990:0.012508:0.005792:0.006777:0.005792:0.013143:0.013181:0.003848:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.006793:0.007466:0.010314:0.007466:0.006523:0.012508:0.018049:0.007466:0.006793:0.011699:0.007466:0.012508:0.006793:0.011680:0.013143:0.013123:0.003848:0.013181:0.006388:0.005330
Arc volumetric-modulated arc therapy :@0.523643:0.358954:0.919896:0.358954:0.919896:0.343199:0.523643:0.343199:0.014239:0.005651:0.012450:0.015028:0.010660:0.012604:0.003848:0.011699:0.018049:0.012508:0.006523:0.005792:0.003848:0.012450:0.006388:0.018049:0.012604:0.013181:0.011699:0.003848:0.013143:0.006523:0.012508:0.013181:0.015028:0.013143:0.005657:0.012450:0.015028:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330
(VMAT) techniques, delivering high doses :@0.523643:0.375372:0.919880:0.375372:0.919880:0.359616:0.523643:0.359616:0.007100:0.013508:0.017684:0.012679:0.008197:0.007100:0.007832:0.006523:0.012508:0.012450:0.011738:0.011738:0.003848:0.013123:0.011699:0.012508:0.007466:0.005330:0.007832:0.013181:0.012508:0.003848:0.003848:0.010660:0.012508:0.005792:0.003848:0.011738:0.012950:0.007832:0.011738:0.003848:0.012950:0.011738:0.007832:0.013181:0.012604:0.007466:0.012508:0.007466:0.005330
in shorter treatment times with high accu-:@0.523643:0.391789:0.914573:0.391789:0.914573:0.376033:0.523643:0.376033:0.003848:0.011738:0.006138:0.007466:0.011738:0.012604:0.005792:0.006523:0.012496:0.005792:0.006138:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.006129:0.006523:0.003848:0.018049:0.012508:0.007466:0.006138:0.015990:0.003848:0.006523:0.011738:0.006138:0.011738:0.003848:0.012950:0.011738:0.006129:0.013143:0.012450:0.012450:0.011699:0.006388
racy levels. This allows for dose escalation.:@0.523643:0.408207:0.914437:0.408207:0.914437:0.392451:0.523643:0.392451:0.005792:0.013143:0.012450:0.010314:0.005330:0.003848:0.012508:0.010660:0.012508:0.003848:0.007466:0.005330:0.005330:0.008197:0.011738:0.003848:0.007466:0.005330:0.013143:0.003848:0.003848:0.012604:0.015990:0.007466:0.005330:0.006042:0.012604:0.005792:0.005330:0.013181:0.012604:0.007466:0.012508:0.005330:0.012508:0.007466:0.012450:0.013143:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330
PROSTATE BRACHYTHERAPY:@0.523636:0.441516:0.828906:0.441516:0.828906:0.421920:0.523636:0.421920:0.013170:0.013641:0.019756:0.012230:0.009878:0.017404:0.009878:0.012230:0.006585:0.013641:0.013641:0.017404:0.018344:0.015993:0.014581:0.009878:0.015993:0.012230:0.013641:0.017404:0.013170:0.014581
Eligible patients have local disease, thus :@0.523636:0.460224:0.919875:0.460224:0.919875:0.444468:0.523636:0.444468:0.010314:0.003848:0.003848:0.012950:0.003848:0.013123:0.003848:0.012508:0.008986:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.008986:0.011738:0.013143:0.010660:0.012508:0.008986:0.003848:0.012604:0.012450:0.013143:0.003848:0.008986:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330:0.008986:0.006523:0.011738:0.011699:0.007466:0.005330
very low risk, low risk, or by exception inter-:@0.523636:0.476641:0.914565:0.476641:0.914565:0.460885:0.523636:0.460885:0.010660:0.012508:0.005792:0.010314:0.004926:0.003848:0.012604:0.015990:0.004926:0.005792:0.003848:0.007466:0.009660:0.005330:0.004926:0.003848:0.012604:0.015990:0.004926:0.005792:0.003848:0.007466:0.009660:0.005330:0.004926:0.012604:0.005792:0.004926:0.013123:0.010314:0.004926:0.012508:0.009236:0.012450:0.012508:0.013123:0.006523:0.003848:0.012604:0.011738:0.004926:0.003848:0.011738:0.006523:0.012508:0.005792:0.006388
mediate risk.:@0.523636:0.493059:0.640822:0.493059:0.640822:0.477303:0.523636:0.477303:0.018049:0.012508:0.013181:0.003848:0.013143:0.006523:0.012508:0.005330:0.005792:0.003848:0.007466:0.009660:0.005330
Ultrasound  transperineal image-guided :@0.541820:0.509476:0.919891:0.509476:0.919891:0.493720:0.541820:0.493720:0.012604:0.003848:0.006523:0.005792:0.013143:0.007466:0.012604:0.011699:0.011738:0.013181:0.005330:0.004018:0.006523:0.005792:0.013143:0.011738:0.007466:0.013123:0.012508:0.005792:0.003848:0.011738:0.012508:0.013143:0.003848:0.009371:0.003848:0.018049:0.013143:0.012950:0.012508:0.006388:0.012950:0.011699:0.003848:0.013181:0.012508:0.013181:0.005330
placement of seeds has shown improved :@0.523636:0.525893:0.919879:0.525893:0.919879:0.510138:0.523636:0.510138:0.013123:0.003848:0.013143:0.012450:0.012508:0.018049:0.012508:0.011738:0.006523:0.006735:0.012604:0.006042:0.006735:0.007466:0.012508:0.012508:0.013181:0.007466:0.006735:0.011738:0.013143:0.007466:0.006735:0.007466:0.011738:0.012604:0.015990:0.011738:0.006735:0.003848:0.018049:0.013123:0.005719:0.012604:0.010660:0.012508:0.013181:0.005330
long-term outcomes with reduction  of :@0.523636:0.542311:0.919902:0.542311:0.919902:0.526555:0.523636:0.526555:0.003848:0.012604:0.011738:0.012950:0.006388:0.006523:0.012508:0.006313:0.018049:0.014778:0.012604:0.011699:0.006523:0.012450:0.012604:0.018049:0.012508:0.007466:0.014778:0.015990:0.003848:0.006523:0.011738:0.014778:0.005711:0.012508:0.013181:0.011699:0.012450:0.006523:0.003848:0.012604:0.011738:0.005330:0.009438:0.012604:0.006042:0.005330
treatment-related complications.  High :@0.523636:0.558728:0.919868:0.558728:0.919868:0.542972:0.523636:0.542972:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.006388:0.005703:0.012508:0.003848:0.013143:0.006523:0.012508:0.013181:0.022591:0.012450:0.012604:0.018049:0.013123:0.003848:0.003848:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330:0.005330:0.017251:0.013143:0.003848:0.012950:0.011738:0.005330
doses of radiation delivered directly (and :@0.523636:0.575146:0.919845:0.575146:0.919845:0.559390:0.523636:0.559390:0.013181:0.012604:0.007466:0.012508:0.007466:0.006735:0.012604:0.006042:0.006735:0.005792:0.013143:0.013181:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.006735:0.013181:0.012508:0.003848:0.003848:0.010660:0.012508:0.005721:0.012508:0.013181:0.006735:0.013181:0.003848:0.005717:0.012508:0.012450:0.006523:0.003848:0.010314:0.006735:0.007100:0.013143:0.011738:0.013181:0.005330
only) result in good tumour outcomes with :@0.523636:0.591563:0.919900:0.591563:0.919900:0.575807:0.523636:0.575807:0.012604:0.011738:0.003848:0.010314:0.007100:0.005388:0.005713:0.012508:0.007466:0.011699:0.003848:0.006523:0.005388:0.003848:0.011738:0.005388:0.012950:0.012604:0.012604:0.013181:0.005374:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.005365:0.012604:0.011699:0.006523:0.012450:0.012604:0.018049:0.012508:0.007466:0.005374:0.015990:0.003848:0.006523:0.011738:0.005330
cancer-control rates equal to surgery and :@0.523636:0.607980:0.919891:0.607980:0.919891:0.592224:0.523636:0.592224:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.006388:0.012450:0.012604:0.011738:0.006523:0.005696:0.012604:0.003848:0.005503:0.005792:0.013143:0.006523:0.012508:0.007466:0.005503:0.012508:0.013123:0.011699:0.013143:0.003848:0.005503:0.006523:0.012604:0.005503:0.007466:0.011699:0.005807:0.012950:0.012508:0.005792:0.010314:0.005503:0.013143:0.011738:0.013181:0.005330
EBRT. However, good  results can also be :@0.523636:0.624398:0.919897:0.624398:0.919897:0.608642:0.523636:0.608642:0.010314:0.011045:0.011798:0.006831:0.005330:0.008755:0.013143:0.012604:0.015990:0.012508:0.010660:0.012508:0.003770:0.005330:0.008755:0.012950:0.012604:0.012604:0.013181:0.005330:0.003410:0.005713:0.012508:0.007466:0.011699:0.003848:0.006523:0.007466:0.008755:0.012450:0.013143:0.011738:0.008755:0.013143:0.003848:0.007466:0.012604:0.008755:0.013123:0.012508:0.005330
obtained in patients with low risk (varying :@0.523636:0.640815:0.919874:0.640815:0.919874:0.625059:0.523636:0.625059:0.012604:0.013123:0.006523:0.013143:0.003848:0.011738:0.012508:0.013181:0.006818:0.003848:0.011738:0.006821:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.006818:0.015990:0.003848:0.006523:0.011738:0.006820:0.003848:0.012604:0.015990:0.006820:0.005792:0.003848:0.007466:0.009660:0.006831:0.007100:0.010660:0.013143:0.005792:0.010314:0.003848:0.011738:0.012950:0.005330
between 85% and 95%) and in intermedi-:@0.523636:0.657233:0.914541:0.657233:0.914541:0.641477:0.523636:0.641477:0.013123:0.012508:0.006523:0.015990:0.012508:0.012508:0.011738:0.006627:0.010660:0.010660:0.014913:0.006639:0.013143:0.011738:0.013181:0.006639:0.010660:0.010660:0.014913:0.007100:0.006639:0.013143:0.011738:0.013181:0.006639:0.003848:0.011738:0.006639:0.003848:0.011738:0.006523:0.012508:0.006319:0.018049:0.012508:0.013181:0.003848:0.006388
ate-risk cases (between 48% and 63%).:@0.523636:0.673650:0.883604:0.673650:0.883604:0.657894:0.523636:0.657894:0.013143:0.006523:0.012508:0.006388:0.005792:0.003848:0.007466:0.009660:0.005330:0.012450:0.013143:0.007466:0.012508:0.007466:0.005330:0.007100:0.013123:0.012508:0.006523:0.015990:0.012508:0.012508:0.011738:0.005330:0.010660:0.010660:0.014913:0.005330:0.013143:0.011738:0.013181:0.005330:0.010660:0.010660:0.014913:0.007100:0.005330
3:@0.883604:0.667993:0.889819:0.667993:0.889819:0.658807:0.883604:0.658807:0.006215
For seed implant, the gland size should :@0.541818:0.690027:0.919885:0.690027:0.919885:0.674271:0.541818:0.674271:0.009333:0.012604:0.005792:0.007585:0.007466:0.012508:0.012508:0.013181:0.007601:0.003848:0.018049:0.013123:0.003848:0.013143:0.011738:0.006523:0.005330:0.007601:0.006523:0.011738:0.012508:0.007589:0.012950:0.003848:0.013143:0.011738:0.013181:0.007601:0.007466:0.003848:0.008178:0.012508:0.007601:0.007466:0.011738:0.012604:0.011699:0.003848:0.013181:0.005330
ideally be below 60 cm  (MRI scans, TRUS :@0.523634:0.706444:0.919864:0.706441:0.919864:0.690685:0.523634:0.690688:0.003848:0.013181:0.012508:0.013143:0.003848:0.003848:0.010314:0.006870:0.013123:0.012508:0.006850:0.013123:0.012508:0.003848:0.012604:0.015990:0.006850:0.010660:0.010660:0.006862:0.012450:0.018049:0.006233:0.006850:0.007100:0.017684:0.011680:0.004349:0.006850:0.007466:0.012450:0.013143:0.011738:0.007466:0.005330:0.006850:0.008197:0.011680:0.012604:0.009583:-0.464621
3:@0.747296:0.700822:0.753511:0.700822:0.753511:0.691637:0.747296:0.691637:0.006215
and DRE).:@0.523643:0.722859:0.615776:0.722859:0.615776:0.707103:0.523643:0.707103:0.013143:0.011738:0.013181:0.005330:0.014316:0.011680:0.010314:0.007100:0.005330
Types of treatment are::@0.541827:0.739276:0.758064:0.739276:0.758064:0.723520:0.541827:0.723520:0.008288:0.010314:0.013123:0.012508:0.007466:0.005330:0.012604:0.006042:0.005330:0.006523:0.005705:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.013143:0.005702:0.012508:0.005330
n   :@0.523636:0.752565:0.546445:0.752565:0.546445:0.744125:0.523636:0.744125:0.009762:0.003566:0.005914:0.003566
Low-dose-rate (LDR) permanent seed :@0.542878:0.755684:0.898574:0.755684:0.898574:0.739929:0.542878:0.739929:0.008890:0.012604:0.015990:0.006388:0.013181:0.012604:0.007466:0.012508:0.006388:0.005792:0.013143:0.006523:0.012508:0.005330:0.007100:0.008890:0.014316:0.011680:0.007100:0.005330:0.013123:0.012508:0.006312:0.018049:0.013143:0.011738:0.012508:0.011738:0.006523:0.005330:0.007466:0.012508:0.012508:0.013181:0.005330
implants:@0.542878:0.772102:0.620618:0.772102:0.620618:0.756346:0.542878:0.756346:0.003848:0.018049:0.013123:0.003848:0.013143:0.011738:0.006523:0.007466
n   :@0.523636:0.785394:0.546445:0.785394:0.546445:0.776954:0.523636:0.776954:0.009762:0.003566:0.005914:0.003566
High-dose-rate (HDR) brachytherapy :@0.542878:0.788513:0.890088:0.788513:0.890088:0.772757:0.542878:0.772757:0.013143:0.003848:0.012950:0.011738:0.006388:0.013181:0.012604:0.007466:0.012508:0.006388:0.005792:0.013143:0.006523:0.012508:0.005330:0.007100:0.013143:0.014316:0.011680:0.007100:0.005330:0.013123:0.005792:0.013143:0.012450:0.011738:0.010314:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330
where transperineal catheters are :@0.542878:0.804931:0.863813:0.804931:0.863813:0.789175:0.542878:0.789175:0.015990:0.011738:0.012508:0.005709:0.012508:0.005330:0.006523:0.005792:0.013143:0.011738:0.007466:0.013123:0.012508:0.005792:0.003848:0.011738:0.012508:0.013143:0.003848:0.005330:0.012450:0.013143:0.006523:0.011738:0.012508:0.006523:0.012508:0.005792:0.007466:0.005330:0.013143:0.005692:0.012508:0.005330
placed in the prostate after loading :@0.542878:0.821348:0.882384:0.821348:0.882384:0.805592:0.542878:0.805592:0.013123:0.003848:0.013143:0.012450:0.012508:0.013181:0.005330:0.003848:0.011738:0.005330:0.006523:0.011738:0.012508:0.005330:0.013123:0.005707:0.012604:0.007466:0.006523:0.013143:0.006523:0.012508:0.005330:0.013143:0.006042:0.006523:0.012508:0.005792:0.005330:0.003848:0.012604:0.013143:0.013181:0.003848:0.011738:0.012950:0.005330
with high-dose-rate isotope: more than :@0.542878:0.837766:0.910395:0.837766:0.910395:0.822010:0.542878:0.822010:0.015990:0.003848:0.006523:0.011738:0.005330:0.011738:0.003848:0.012950:0.011738:0.006388:0.013181:0.012604:0.007466:0.012508:0.006388:0.005792:0.013143:0.006523:0.012508:0.005330:0.003848:0.007466:0.012604:0.006523:0.012604:0.013123:0.012508:0.005330:0.005330:0.018049:0.012604:0.005682:0.012508:0.005330:0.006523:0.011738:0.013143:0.011738:0.005330
one fraction is used for this technique.:@0.542878:0.854183:0.895495:0.854183:0.895495:0.838427:0.542878:0.838427:0.012604:0.011738:0.012508:0.005330:0.006042:0.005792:0.013143:0.012450:0.006523:0.003848:0.012604:0.011738:0.005330:0.003848:0.007466:0.005330:0.011699:0.007466:0.012508:0.013181:0.005330:0.006042:0.012604:0.005792:0.005330:0.006523:0.011738:0.003848:0.007466:0.005330:0.006523:0.012508:0.012450:0.011738:0.011738:0.003848:0.013123:0.011699:0.012508:0.005330
n   :@0.523636:0.867467:0.546445:0.867467:0.546445:0.859026:0.523636:0.859026:0.009762:0.003566:0.005914:0.003566
Brachytherapy plus external beam :@0.542878:0.870586:0.870469:0.870586:0.870469:0.854830:0.542878:0.854830:0.011045:0.005792:0.013143:0.012450:0.011738:0.010314:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.013123:0.003848:0.011699:0.007466:0.005330:0.012508:0.009236:0.006523:0.012508:0.006185:0.011738:0.013143:0.003848:0.005330:0.013123:0.012508:0.013143:0.018049:0.005330
radiotherapy. In these cases, a lower :@0.542878:0.887003:0.890973:0.887003:0.890973:0.871247:0.542878:0.871247:0.005792:0.013143:0.013181:0.003848:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.005330:0.004349:0.011738:0.005330:0.006523:0.011738:0.012508:0.007466:0.012508:0.005330:0.012450:0.013143:0.007466:0.012508:0.007466:0.005330:0.005330:0.013143:0.005330:0.003848:0.012604:0.015990:0.012508:0.005792:0.005330
dose of external beam radiotherapy is :@0.542878:0.903421:0.904786:0.903421:0.904786:0.887665:0.542878:0.887665:0.013181:0.012604:0.007466:0.012508:0.005330:0.012604:0.006042:0.005330:0.012508:0.009236:0.006523:0.012508:0.006173:0.011738:0.013143:0.003848:0.005330:0.013123:0.012508:0.013143:0.018049:0.005330:0.005792:0.013143:0.013181:0.003848:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.003848:0.007466:0.005330
delivered to the para-prostatic tissue :@0.542878:0.919838:0.889863:0.919838:0.889863:0.904082:0.542878:0.904082:0.013181:0.012508:0.003848:0.003848:0.010660:0.012508:0.005721:0.012508:0.013181:0.005330:0.006523:0.012604:0.005330:0.006523:0.011738:0.012508:0.005330:0.013123:0.013143:0.005792:0.013143:0.006388:0.013123:0.005696:0.012604:0.007466:0.006523:0.013143:0.006523:0.003848:0.012450:0.005330:0.006523:0.003848:0.007466:0.007466:0.011699:0.012508:0.005330
(45 Gy to 50 Gy) compared to 74 Gy :@0.542878:0.936255:0.889324:0.936255:0.889324:0.920499:0.542878:0.920499:0.007100:0.010660:0.010660:0.005330:0.016779:0.010314:0.005330:0.006523:0.012604:0.005330:0.010660:0.010660:0.005330:0.016779:0.010314:0.007100:0.005330:0.012450:0.012604:0.018049:0.013123:0.013143:0.005721:0.012508:0.013181:0.005330:0.006523:0.012604:0.005330:0.010660:0.010660:0.005330:0.016779:0.010314:0.005330